- Home
- AJX vs MYO Comparison
AJX vs MYO Comparison
Compare AJX & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AJX
- MYO
- Stock Information
- Founded
- AJX 2014
- MYO 2004
- Country
- AJX United States
- MYO United States
- Employees
- AJX N/A
- MYO N/A
- Industry
- AJX Real Estate Investment Trusts
- MYO Industrial Specialties
- Sector
- AJX Real Estate
- MYO Health Care
- Exchange
- AJX Nasdaq
- MYO Nasdaq
- Market Cap
- AJX 141.2M
- MYO 113.3M
- IPO Year
- AJX 2015
- MYO 2017
- Fundamental
- Price
- AJX $3.00
- MYO $4.78
- Analyst Decision
- AJX Buy
- MYO Strong Buy
- Analyst Count
- AJX 2
- MYO 4
- Target Price
- AJX $6.00
- MYO $7.75
- AVG Volume (30 Days)
- AJX 140.6K
- MYO 199.1K
- Earning Date
- AJX 10-21-2024
- MYO 11-06-2024
- Dividend Yield
- AJX 8.00%
- MYO N/A
- EPS Growth
- AJX N/A
- MYO N/A
- EPS
- AJX N/A
- MYO N/A
- Revenue
- AJX N/A
- MYO $25,239,125.00
- Revenue This Year
- AJX N/A
- MYO $53.19
- Revenue Next Year
- AJX N/A
- MYO $39.01
- P/E Ratio
- AJX N/A
- MYO N/A
- Revenue Growth
- AJX N/A
- MYO 36.23
- 52 Week Low
- AJX $2.92
- MYO $2.51
- 52 Week High
- AJX $6.01
- MYO $5.64
- Technical
- Relative Strength Index (RSI)
- AJX 40.08
- MYO 60.02
- Support Level
- AJX $2.92
- MYO $4.56
- Resistance Level
- AJX $3.20
- MYO $5.15
- Average True Range (ATR)
- AJX 0.09
- MYO 0.37
- MACD
- AJX -0.00
- MYO 0.03
- Stochastic Oscillator
- AJX 28.07
- MYO 65.87
About AJX Great Ajax Corp.
Great Ajax Corp is an externally managed real estate company. The company's primary business is acquiring, investing in and managing a portfolio of mortgage loans. The company is focused on acquisitions of re-performing loans (RPLs) including residential mortgage loans and small balance commercial mortgage loans (SBC loans). Great Ajax operates in a single segment. The company also holds real-estate owned (REO) properties acquired upon the foreclosure, other settlement of owned non-performing loans.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).